These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9106405)

  • 1. HIV vaccine and genital secretory immune response.
    Stefanache-Guihard AI
    Rom J Virol; 1995; 46(1-2):85-98. PubMed ID: 9106405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
    Mestecky J
    J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
    Hirbod T; Broliden K
    J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
    Firoz Mian M; Ashkar AA
    Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards an AIDS mucosal vaccine: an overview.
    Yuki Y; Nochi T; Kiyono H
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment.
    Kaushic C; Ferreira VH; Kafka JK; Nazli A
    Am J Reprod Immunol; 2010 Jun; 63(6):566-75. PubMed ID: 20384619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic uniqueness of the genital tract: challenge for vaccine development.
    Mestecky J; Moldoveanu Z; Russell MW
    Am J Reprod Immunol; 2005 May; 53(5):208-14. PubMed ID: 15833098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal vaccination strategies for women.
    Kozlowski PA; Cu-Uvin S; Neutra MR; Flanigan TP
    J Infect Dis; 1999 May; 179 Suppl 3():S493-8. PubMed ID: 10099127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
    Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M
    J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM; Ahlers JD
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immune system of the human genital tract.
    Mestecky J; Fultz PN
    J Infect Dis; 1999 May; 179 Suppl 3():S470-4. PubMed ID: 10099122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal HIV vaccines: a holy grail or a dud?
    Azizi A; Ghunaim H; Diaz-Mitoma F; Mestecky J
    Vaccine; 2010 May; 28(24):4015-26. PubMed ID: 20412879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus.
    Mestecky J; Kutteh WH; Jackson S
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S11-20. PubMed ID: 7865284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
    Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
    J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells.
    Kaushic C
    Am J Reprod Immunol; 2011 Mar; 65(3):253-60. PubMed ID: 21223427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge.
    Dumais N; Patrick A; Moss RB; Davis HL; Rosenthal KL
    J Infect Dis; 2002 Oct; 186(8):1098-105. PubMed ID: 12355360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG surfaces as an important component in mucosal protection.
    Robert-Guroff M
    Nat Med; 2000 Feb; 6(2):129-30. PubMed ID: 10655090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.